
Sign up to save your podcasts
Or


Dr. Charlie Wykoff describes the treat-and-extend (TREX) approach for the treatment of wet AMD. He then explains the study design and the 3-year results of the TREX-AMD trial. The full reference of the article is:
Wykoff, C. C., Ou, W. C., Croft, D. E., Payne, J. F., Brown, D. M., Clark, W. L., . . . Group, T.-A. S. (2017). Neovascular age-related macular degeneration management in the third year: final results from the TREX-AMD randomised trial. Br J Ophthalmol. doi:10.1136/bjophthalmol-2017-310822
Please leave your comments in the iTunes show description or email to: [email protected]
By Keyvan Koushan, MD, FRCSC4.4
1111 ratings
Dr. Charlie Wykoff describes the treat-and-extend (TREX) approach for the treatment of wet AMD. He then explains the study design and the 3-year results of the TREX-AMD trial. The full reference of the article is:
Wykoff, C. C., Ou, W. C., Croft, D. E., Payne, J. F., Brown, D. M., Clark, W. L., . . . Group, T.-A. S. (2017). Neovascular age-related macular degeneration management in the third year: final results from the TREX-AMD randomised trial. Br J Ophthalmol. doi:10.1136/bjophthalmol-2017-310822
Please leave your comments in the iTunes show description or email to: [email protected]

43 Listeners

18 Listeners

97 Listeners

5 Listeners

4 Listeners

8 Listeners

22 Listeners

52 Listeners

10 Listeners

16 Listeners

18 Listeners

0 Listeners

1 Listeners

19 Listeners

0 Listeners